Literature DB >> 10618353

Acute myocardial infarction: thrombolysis.

E J Topol1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618353      PMCID: PMC1729274          DOI: 10.1136/heart.83.1.122

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  8 in total

1.  Perivalvular abscesses in infective endocarditis.

Authors:  C M Oakley
Journal:  Eur Heart J       Date:  1999-02       Impact factor: 29.983

2.  Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial.

Authors:  S J Brener; L A Barr; J E Burchenal; K E Wolski; M B Effron; E J Topol
Journal:  Am J Cardiol       Date:  1999-09-15       Impact factor: 2.778

3.  Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.

Authors:  K C Wu; E A Zerhouni; R M Judd; C H Lugo-Olivieri; L A Barouch; S P Schulman; R S Blumenthal; J A Lima
Journal:  Circulation       Date:  1998-03-03       Impact factor: 29.690

4.  More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.

Authors:  R W Smalling; C Bode; J Kalbfleisch; S Sen; P Limbourg; F Forycki; G Habib; R Feldman; S Hohnloser; A Seals
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

5.  Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction.

Authors:  H Ito; A Okamura; K Iwakura; T Masuyama; M Hori; S Takiuchi; S Negoro; Y Nakatsuchi; Y Taniyama; Y Higashino; K Fujii; T Minamino
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

6.  Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries.

Authors:  P A Gurbel; V L Serebruany; A R Shustov; R D Bahr; C Carpo; E M Ohman; E J Topol
Journal:  J Am Coll Cardiol       Date:  1998-06       Impact factor: 24.094

7.  The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction.

Authors:  T R Porter; S Li; R Oster; U Deligonul
Journal:  Am J Cardiol       Date:  1998-11-15       Impact factor: 2.778

8.  Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction.

Authors:  F J Neumann; R Blasini; C Schmitt; E Alt; J Dirschinger; M Gawaz; A Kastrati; A Schömig
Journal:  Circulation       Date:  1998-12-15       Impact factor: 29.690

  8 in total
  4 in total

Review 1.  Coronary Disease: Acute myocardial infarction: failed thrombolysis.

Authors:  M A de Belder
Journal:  Heart       Date:  2001-01       Impact factor: 5.994

2.  Gypenosides alleviate myocardial ischemia-reperfusion injury via attenuation of oxidative stress and preservation of mitochondrial function in rat heart.

Authors:  Haijie Yu; Qigang Guan; Liang Guo; Haishan Zhang; Xuefeng Pang; Ying Cheng; Xingang Zhang; Yingxian Sun
Journal:  Cell Stress Chaperones       Date:  2016-01-22       Impact factor: 3.667

Review 3.  Pharmacologic reperfusion therapy for acute myocardial infarction.

Authors:  Harry C Lowe; Briain D Mac Neill; Frans Van de Werf; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2002-12       Impact factor: 2.300

4.  No-reflow phenomenon and endothelial glycocalyx of microcirculation.

Authors:  Alexander V Maksimenko; Askar D Turashev
Journal:  Biochem Res Int       Date:  2011-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.